Accuracy of recommendations by a conversational AI cancer mentor app
Authors: Prof. Talia Golan , Dr. Ofer Purim, Prof. Danny Rosin, Dr. Eli Sapir, Prof. Moshe Gatt, Dr. Tomer Charas, Dr. Ilya Iofin, Prof. Ido Wolf, Bozhena Haikin , Dr. Daniel A. Vorobiof. Researched by: investigators from Sheba Medical Center, Shaarei Tzedek Medical Center, Assuta Ashdod University Medical Center, Hadassah Medical Center, Rambam Hospital, Ichilov […]
Multi-institutional validation survey on Belong.life’s conversational artificial intelligence (AI) oncology mentor, “Dave”.
Authors: Prof. Talia Golan , Dr. Ofer Purim, Prof. Danny Rosin, Dr. Eli Sapir, Prof. Moshe Gatt, Dr. Tomer Charas, Dr. Ilya Iofin, Prof. Ido Wolf, Bozhena Haikin , Dr. Daniel A. Vorobiof. Researched by: investigators from Sheba Medical Center, Shaarei Tzedek Medical Center, Assuta Ashdod University Medical Center, Hadassah Medical Center, Rambam Hospital, Ichilov […]
Comments for Compassionate Machines. The Ethics of “Artificial Empathy”
Daniel Vorobiof, MD. | Chief Medical Director, Belong.life Jama Oncology, May 2, 2024, doi:10.1001/jamaoncol.2024.0824. I read with interest the Viewpoint opinion written by Drs Koranteng, Lewis and Abel entitled Compassionate Machines. The Ethics of “Artificial Empathy” (Jama Oncology, May 2, 2024, doi:10.1001/jamaoncol.2024.0824) We at Belong.life recently launched the first conversational AI Cancer mentor (Dave) application […]
The Prevalence of Cannabis-related Arrhythmias in Patients with Cancer: Real-world Data Evidence of Patient-reported Outcomes
A Laish-Farkash, L Vasilenko, Noy Moisa, Daniel Vorobiof. Israel Medical Association Journal, vol 25:4:292-297, 2023. Abstract Background: Cannabis consumption is suspected of causing arrhythmias and potentially sudden death. Objectives: To investigate prevalence and temporal relationships between cannabis use and onset of symptomatic arrhythmias among cancer patients using Belong.life, a digital patient powered network application. Methods: […]
Real-world behavioral practices of cancer patients: misconceptions compromising daily life activities
ESMO Real World Data and Digital Oncology Journal | VOLUME 4, 100041, JUNE 2024. Published: May 13, 2024DOI. Authors: E. Shachar, S. Peleg-Hasson, D. Vorobiof, E. Waller, T. Safra, I. Wolf Highlights Background Health-related quality of life is commonly used as an endpoint in clinical trials. While it evaluates the presence of symptoms, it does not measure […]
Weight Loss Targets Realization by Patients Living With Overweight or Obesity – Real World Data
Published: 12 May 2024. Participants: Dan Oieru, Bozhena Haikin, Noy Moisa, Tel Aviv University – School of Medicine, Maccabi Healthcare Services, Belong.Life inc. Background Belong is a digital platform which provides professionally moderated digital communities for several chronic conditions. This platform connects patients, healthcare professionals and care management solutions. MyWeight (MW) is a new patient […]
Real-world behavioral restrictional practices of cancer patients (pts)
Real world data evidence on cancer patients awareness and knowledge of cancer associated thrombosis (CAT) events
Lessons Learned from the Implementation of a Person-Centred Digital Health Platform in Cancer Care
Published: 29 September 2022 Abstract The SARS-CoV-2 (COVID-19) pandemic has accelerated the development and use of digital health platforms to support individuals with health-related challenges. This is even more frequent in the field of cancer care as the global burden of the disease continues to increase every year. However, optimal implementation of these platforms into […]
Financial Toxicity In Cancer Patients Receiving Immunotherapy Drugs
Researched by Belong.Life and published by ESMO, 2020 Authors: D Vorobiof, L Hasid, A Litvin, I Deutsch, E Malki. FT has been described as the harmful personal financial burden faced by all patients receiving cancer treatments. Physicians should not be waiting for behavioural changes such as poor compliance, or low or nonadherence, caused by financial […]
